Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate

Revista Espanola de Quimioterapia

Volumn 17, Issue 3, 2004, Pages 263-265

  Aznar, Esteban ^a   Buendia B ^a   Garcia Penuela E ^a   Escudero, E ^a   Alarcon T ^a   Lopez Brea M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Community acquired infection; Enterococcus faecalis; Urinary tract infection; Vancomycin resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; COTRIMOXAZOLE; FOSFOMYCIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; DEVICE; DIFFUSION; DILUTION; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; URINARY TRACT INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; ENTEROCOCCUS FAECALIS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MIDDLE AGED; URINARY TRACT INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 9644287797     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Murray, B.E. The life and times of enterococcus. Clin Microbiol Rev 1990; 3: 45-65.
2. Uttley, A.H.C., Collins, C.H., Naidoo, J., George, R.C. Vancomycin-resistant enterococci. Lancet 1988; i: 57-58.
3. Wendt, C., Krause, C., Xander, L.U., Loffler, D., Floss, H. Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany. J Hosp Infect 1999; 42: 193-200.
4. Cetinkaya, Y., Falk, P., Glen Mayhall, C. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13: 686-707.
5. Bates, J., Jordens, J.Z., Griffiths, D.T. Farm animals as putative reservoir for vancomycin-resistant enterococcal infection in man. Antimicrob Agents Chemother 1995; 39: 781-785.
6. Van Horn, K., Tóth, C., Kariyama, R., Mitsuhaka, R., Kumon, H. Evaluation of 15 motility media and a direct microscopic method for detection of motility in enterococci. J Clin Microbiol 2002; 40: 2476-2479.
7. NCCLS. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. NCCLS document M100-S12. NCCLS, Wayne, Pennsylvania 2002.
8. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-Sixth edition. NCCLS document M7-A6. NCCLS, Wayne, Pennsylvania 2003.
9. Robredo, B., Singh, K.V., Baquero, F., Murray, B.E., Torres, C. Vancomycin resistant enterococci isolated from animals and food. Int J Food Microbiol 2000; 54: 197-204.
10. Arthur, M., Courvalain, P. Genetics and mechanisms of glycopeptide resistance in Enterococci. Antimicrob Agents Chemother 1993; 37: 1563-1571.
11. Fines, M., Pericón, B., Reynolds, P., Sham, D.F., Courvalain, P. Van E a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999; 43: 2161-2164.
12. Pericón, B., Reynolds, P., Courvalain, P. Van D type glycopeptide resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997; 41: 2016-2018.
13. Bell, J.M., Paton, J.C., Turnidge, J. Emergence of vancomycin-resistant Enterococci in Australia: Phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187-2190.
14. Hashimoto, Y., Tanimoto, K., Ozawa, Y., Murata, T., Ike, Y. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance. FEMS Microbiol Lett 2000; 185: 247-254.
15. Lauderdale, T.L., McDonald, L.C., Shiau, YR. et al. Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother 2002; 46: 525-527.
16. Eom, J.S., Hwang, I.S., Hwang, B.Y. et al. Emergence of vanA genotype vancomycin-resistant Enterococci with low or moderate levels of teicoplanin resistance in Korea. J Clin Microbiol 2004; 42: 1785-1786.